ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
iSpecimen Inc

iSpecimen Inc (ISPC)

2.81
-0.06
(-2.09%)
At close: 30 December 8:00AM
2.80
-0.01
( -0.36% )
After Hours: 11:46AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.80
Bid
2.68
Offer
3.20
Volume
311,737
2.64 Day's Range 2.95
2.6216 52 Week Range 12.20
Market Cap
Previous Close
2.87
Open
2.8831
Last Trade
42
@
2.81
Last Trade Time
11:59:44
Financial Volume
US$ 868,084
VWAP
2.7847
Average Volume (3m)
493,001
Shares Outstanding
962,637
Dividend Yield
-
PE Ratio
-0.24
Earnings Per Share (EPS)
-11.53
Revenue
9.93M
Net Profit
-11.1M

About iSpecimen Inc

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement proce... iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery. Geographically, it has a presence in the Americas; Europe, Middle East, and Africa, and Asia Pacific. Show more

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Wilmington, Delaware, USA
Founded
-
iSpecimen Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker ISPC. The last closing price for iSpecimen was US$2.87. Over the last year, iSpecimen shares have traded in a share price range of US$ 2.6216 to US$ 12.20.

iSpecimen currently has 962,637 shares in issue. The market capitalisation of iSpecimen is US$2.76 million. iSpecimen has a price to earnings ratio (PE ratio) of -0.24.

ISPC Latest News

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for...

iSpecimen Reports Third Quarter 2024 Results

LEXINGTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for...

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.82-22.65193370173.623.972.62167371092.969395CS
4-1.3-31.70731707324.14.352.62164128393.13197783CS
12-2.36-45.73643410855.168.32.62164930014.78354513CS
26-4-58.82352941186.811.82.621610381905.68547017CS
52-7-71.42857142869.812.22.621615356666.88177815CS
156-226.07-98.7765980688228.87246.9842.621667982530.36709019CS
260-122.6-97.7671451356125.4579.5982.6216997781132.68065086CS

ISPC - Frequently Asked Questions (FAQ)

What is the current iSpecimen share price?
The current share price of iSpecimen is US$ 2.80
How many iSpecimen shares are in issue?
iSpecimen has 962,637 shares in issue
What is the market cap of iSpecimen?
The market capitalisation of iSpecimen is USD 2.76M
What is the 1 year trading range for iSpecimen share price?
iSpecimen has traded in the range of US$ 2.6216 to US$ 12.20 during the past year
What is the PE ratio of iSpecimen?
The price to earnings ratio of iSpecimen is -0.24
What is the cash to sales ratio of iSpecimen?
The cash to sales ratio of iSpecimen is 0.27
What is the reporting currency for iSpecimen?
iSpecimen reports financial results in USD
What is the latest annual turnover for iSpecimen?
The latest annual turnover of iSpecimen is USD 9.93M
What is the latest annual profit for iSpecimen?
The latest annual profit of iSpecimen is USD -11.1M
What is the registered address of iSpecimen?
The registered address for iSpecimen is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the iSpecimen website address?
The website address for iSpecimen is www.ispecimen.com
Which industry sector does iSpecimen operate in?
iSpecimen operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VINCVincerx Inc
US$ 0.32
(64.95%)
23.04M
AERTAeries Technology Inc
US$ 1.39
(58.51%)
1.96M
CCTGCCSC Technology International Holdings Ltd
US$ 2.45
(49.39%)
3.11M
ARTWArts Way Manufacturing Co Inc
US$ 3.28
(34.43%)
242.28k
VRPXVirpax Pharmaceuticals Inc
US$ 0.501
(22.20%)
2.26M
LITMSnow Lake Resources Ltd
US$ 1.10
(-31.25%)
9.69M
XAIRBeyond Air Inc
US$ 0.38
(-13.64%)
1.9M
SHMDSCHMID Group NV
US$ 2.75
(-12.42%)
24.28k
COEPCoeptis Therapeutics Holdings Inc
US$ 0.1601
(-12.13%)
340.97k
AVGRAvinger Inc
US$ 0.85
(-11.92%)
271.51k
VINCVincerx Inc
US$ 0.32
(64.95%)
23.04M
CEROCERo Therapeutics Holdings Inc
US$ 0.0628
(4.67%)
15.27M
XTIAXTI Aerospace Inc
US$ 0.0414
(4.81%)
13.19M
LITMSnow Lake Resources Ltd
US$ 1.10
(-31.25%)
9.69M
INTZIntrusion Inc
US$ 1.94
(-10.19%)
7.78M

ISPC Discussion

View Posts
subslover subslover 1 week ago
And yesterday she was down 25% so seems as though the day traders found her. 🙄
👍️0
tw0122 tw0122 1 week ago
Some specimen volume $3.40 + 14%
👍️0
subslover subslover 2 weeks ago
It briefly shot up to $5:39 about 1 hour ago🤣
👍️0
tw0122 tw0122 2 weeks ago
They sent it to $5 last month..$3.87 +'12% 
👍️0
subslover subslover 2 weeks ago
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
Newsfile Corp.
Newsfile Corp
Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today positive results attributed to its Next Day Quote Program ("NDQ"). This next-day quote service for researchers and providers is tailored to accelerate the biospecimen transaction process and delivers accurate biospecimen sample pricing within 24 hours of receiving the customer request. Next Day Quotes are possible to implement only when the Company knows the supplier's data on their specific capabilities and pricing, as well as understands the customer's requirements.

Recognizing the need for timely access to high-quality biospecimens to advance life science research, iSpecimen had introduced NDQ to offer researchers and providers with swift and accurate sample pricing. From fresh whole blood and prescreened mutation-characterized blocks to an array of clinically collected remnant, banked and prospective biospecimens, most quotes are provided within a day of receiving the inquiry.

Since introducing the program in 2023 and the recently completed build of a search tool, quotes can be created within minutes. With this capability, the Company's sales mix has increasingly shifted towards NDQ. In November 2024, 30% of all sales opportunities were Next Day Quotes. Of all quotes that were generated in November 2024, 48% were Next Day Quotes. Meanwhile, the conversion rate was high for Next Day Quotes. 60% of all purchase orders were Next Day Quotes1.

Leslie Hoyt, Senior Vice President of Operations commented, "Our customers have responded enthusiastically to iSpecimen's Next Day Quote Program. For the first six months of the program, NDQ has consistently yielded strong results, driving an estimated 60% of sales. The data continue to show that if we quote within the next business day, we greatly increase the likelihood of receiving a signed purchase order. Current and future customers respond positively because time matters."

Ms. Hoyt further commented, "We continue to enhance our internal databases and search tools to proactively harvest data, ensuring the viability of Next day Quote program while increasing the frequency with which Next Day Quotes are possible. This offering accelerates our operational timeline and the customer decision journey. Ultimately next day quotes allow researchers and providers to focus on what matters most, and iSpecimen to be a valuable service provider for all customers."
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
ISPC BLOWING UP
👍️0
Invest-in-America Invest-in-America 2 months ago
ISPC: I'm laughing at my OWN post back then!! (I should be doing stand-up in LA.)
👍️0
tw0122 tw0122 2 months ago
Still 600k
Floater at $5.10 will the hedgies hit it more or is it done 
👍️0
tw0122 tw0122 2 months ago
They claim more specimens to be delivered more revenue $5,59 + 25% 
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
PRESSURE BUILDING
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
ISPC POST SPLITER WANTS TO GO
👍️0
tw0122 tw0122 2 months ago
ISPC 9.08 + 102%
👍️0
tw0122 tw0122 2 months ago
Careful ..$4.11 offering
iSpecimen Inc.
We are offering on a best-efforts basis up to 1,216,545 shares of our common stock, par value $0.0001 per share (the “Shares”) at an assumed public offering price of $4.11 per share, which was the reported closing price of our common stock on the Nasdaq Capital Market (“Nasdaq”), on October 15, 2024.
We are also offering to each purchaser of Shares that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of our outstanding shares of common stock immediately following the consummation of this offering the opportunity to purchase one Pre-Funded Warrant (in lieu of one share of common stock) (each a “Pre-Funded Warrant”). A holder of Pre-Funded Warrants will not have the right to exercise any portion of its Pre-Funded Warrants if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the election of the holder, such limit may be increased to up to 9.99%) of the number of shares of common stock outstanding immediately after giving effect to such exercise. Each Pre-Funded Warrant will be exercisable for one share of common stock. The purchase price of each Pre-Funded Warrant will be equal to the price per Share, minus $0.0001, and the remaining exercise price of each Pre-Funded Warrant will equal $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each Pre-Funded Warrant we sell (without regard to any limitation on exercise set forth therein), the number of Shares we are offering will be decreased on a one-for-one basis.
We are registering the Shares and the shares of common stock issuable from time to time upon the exercise of the Pre-Funded Warrants hereby.
Our common stock is listed on Nasdaq under the symbol “ISPC”. On October 15, 2024, the reported closing price of our common stock was $4.11 per share. There is no established public trading market for the Pre-Funded Warrants. We do not intend to apply for listing of the Pre-Funded Warrants on any securities exchange or recognized trading system. Without an active trading market, the liquidity of the Pre-Funded Warrants will be limited.
The public offering price for the Shares in this offering will be determined at the time of pricing and may be at a discount to the then current market price. Therefore, the assumed public offering price used throughout this prospectus may not be indicative of the final offering price. The final public offering price will be determined through negotiation between us and the investors based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering.
The Shares and Pre-Funded Warrants, if any, will be offered at a fixed price and are expected to be issued in a single closing. We expect this offering to be completed not later than two business days following the effective date of the registration statement of which this prospectus forms a part (the “Registration Statement”), and we will deliver all securities to be issued in connection with this offering delivery versus payment/receipt versus payment upon receipt of investor funds received by us. Accordingly, neither we nor WestPark Capital, Inc., whom we have engaged as the exclusive placement agent for this offering (“WestPark” or the “Placement
TABLE OF CONTENTS
Agent”) have made any arrangements to place investor funds in an escrow account or trust account since the Placement Agent will not receive investor funds in connection with the sale of the securities offered hereunder.
We have engaged WestPark as our exclusive placement agent to use its reasonable best efforts to solicit offers to purchase our securities in this offering. The Placement Agent is not purchasing or selling any of the securities we are offering and is not required to arrange for the purchase or sale of any specific number or dollar amount of the securities. Because there is no minimum offering amount required as a condition to closing in this offering the actual public offering amount, Placement Agent’s fee, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above and throughout this prospectus. We have agreed to pay the Placement Agent the Placement Agent fees set forth in the table below. See “Plan of Distribution” in this prospectus for more information.
? ? ?
Per Share
? ?
Total(2)
?
Public Offering Price
? ? ? $ ? ? ? ? $ ? ?
Placement Agent fees(1)
? ? ? $ ? ? ? ? $ ? ?
Proceeds, before expenses, to us
? ? ? $ ????? ? ? ? ? $ ????? ? ?
?
(1)
In connection with this offering, we have agreed to pay to WestPark as placement agent a cash fee equal to 4% of the gross proceeds received by us in the offering. We have also agreed to reimburse WestPark for all expenses related to the offering up to $[ ] for reimbursement of legal expenses and other out-of-pocket expenses in connection with its engagement as placement agent See “Plan of Distribution.”
?
(2)
Assumes investors purchase only Shares and no Pre-Funded Warrants in this offering.
?
Investing in our securities involves a high degree of risk. See the section entitled “Risk Factors” beginning on page 16 of the prospectus. You should carefully consider these risk factors, as well as the information contained in this prospectus before you invest.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
WestPark Capital, Inc.
The date of this prospectus is ???????? ??, 2024
TABLE OF CONTENTS?

TABLE OF CONTENTS
? ? ?
Page
?
ABOUT THIS PROSPECTUS
? ? ? ? ii ? ?
PROSPECTUS SUMMARY
? ? ? ? 1 ? ?
THE OFFERING
? ? ? ? 13 ? ?
SUMMARY FINANCIAL DATA
? ? ? ? 15 ? ?
RISK FACTORS
? ? ? ? 16 ? ?
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
? ? ? ? 42 ? ?
USE OF PROCEEDS
? ? ? ? 43 ? ?
CAPITALIZATION
? ? ? ? 44 ? ?
MANAGEMENT
? ? ? ? 46 ? ?
DESCRIPTION OF OUR SECURITIES
? ? ? ? 52 ? ?
PLAN OF DISTRIBUTION
? ? ? ? 57 ? ?
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
? ? ? ? 60 ? ?
LEGAL MATTERS
? ? ? ? 65 ? ?
EXPERTS
? ? ? ? 65 ? ?
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
? ? ? ? 65 ? ?
WHERE YOU CAN FIND MORE INFORMATION
? ? ? ? 66 ? ?
This prospectus contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control. See “Risk Factors” and “Special Note Regarding Forward-Looking Statements.”
👍️0
tw0122 tw0122 2 months ago
ISPC $8.15 +70%
👍️0
Awl416 Awl416 2 months ago
$6 to 2.50 to 7 bucks yeah ok
👍️0
Awl416 Awl416 2 months ago
LOL
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
EXIT THAT TOP....
👍️0
ming1234 ming1234 3 months ago
holding until tomorrow 10$+ potential
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
POST SPLITS BLOWING UP LIKE CRAZY
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC READY TO GO...AFTER HOURS PLAY OF THE DAY
👍️0
Awl416 Awl416 3 months ago
Oink oink
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC MICRO FLOAT
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC...NEXT GLMD
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC BLOWING UP
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC..THERE IT GOES
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC...FIRST MAGNET UP AND THEN THE SECOND MAGNET AT 5.90 NEXT
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC HERE WE GO....MAGNET 5.46
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC COME ON GIVE US ANOTHER GLMD
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC NEXT ONE TO BEAST....LOW FLOAT MONSTER
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
LOW FLOAT MONSTER
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ISPC POST RS 580K FLOAT
👍️0
glenn1919 glenn1919 6 months ago
ISCP...................https://stockcharts.com/h-sc/ui?s=ISCP&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 6 months ago
ISPC...55s clearing here on Volume...🥳
👍️0
Invest-in-America Invest-in-America 7 months ago
ISPC: Now that was a rather JADED, CYNICAL, commentary on 'Wall Street' generally, Dude!! (He can't even SEE my posts. By the way, I'm now HALF-WAY through Monk's Nobel-Prize-winning treatise entitled, "American Cars of 1958". Monk's book also comes with a CD, which shows Monk & Family test-driving Monk's patented. "Electro-Hydrogen-Fuel-Cell-Aero-Hybrid" car prototype; see below!!)

👍️0
Invest-in-America Invest-in-America 7 months ago
ISPC: Well now, this one is quite a 'SPECIMEN' here in the Post-M today, Peeps. (No pun intended.)
👍️0
Monksdream Monksdream 7 months ago
Sooner or later the sun shines on every dog’s ass
👍️0
subslover subslover 7 months ago
She found some new sneakers
👍️0
The Night Stalker The Night Stalker 7 months ago
next in line
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
ARCA BOOM THE BID TO GET THE PUSH
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
ALGO PROGRAMMED AT 66C
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
HWERE WE GO...66C COMING IN FAST
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
OKAY QUICK SCALP TO 66c...
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
ISPC.. TRICKY HERE AT 43...SLEPT ON THAT ONE
👍️0
TheFinalCD TheFinalCD 8 months ago
.444
👍️0
Monksdream Monksdream 10 months ago
ISPC 10Q due March 13
👍️0
Lilman72003 Lilman72003 1 year ago
Call me Tony Gwynn cause your boy just hit an easy double
👍️0
Lilman72003 Lilman72003 1 year ago
I’m here all by myself making a killing
👍️0
Lilman72003 Lilman72003 1 year ago
moving with volume
👍️0

Your Recent History

Delayed Upgrade Clock